Diligence memo · auto-generated · as of July 2, 2026
Oncoquest Pharma Usa, Inc
Oncoquest Pharma Usa, Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Oncoquest Pharma Usa, Inc operates in Pharmaceuticals, based in MIRYANG SI, GYEONGSANGNAMDO.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Oncoquest Pharma Usa, Inc has raised $870K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $510K on 2020-12-10.
Most recent recorded round closed around 2021-04-27.
Valuation (modeled)modeled
Provath models Oncoquest Pharma Usa, Inc at approximately $11M (range $202K–$93M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.79× the median modeled value of Pre-Seed Pharmaceuticals companies in 2019–2021 (46 peers) — value vs value, same stage and era. Within the normal band (79% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 5 months.
Last raise 5.2 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 18% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 18% of those peers.
Closest niche peers: Elion Oncology, Inc., Cyclone Therapeutics, Inc., Sonnet Biotherapeutics, Inc., Fastball Capital Group, Llc, TamRx, LLC.
Peoplefiled
4 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.